Keeping MS under control: New treatments finally bring hope to Floridians living with multiple sclerosis
Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...
FDA warns of serious allergic reactions with some multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
The American Journal of Managed Care7d
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
Medscape8d
FDA Adds Anaphylaxis Risk Warning to Multiple Sclerosis Drug Glatiramer Acetate
From 1996-2024, 82 cases of anaphylaxis associated with glatiramer acetate were reported to the FDA Adverse Event Reporting ...
GlobalData on MSN7d
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...
Medindia3d
Myelin Repair Offers Promise for Vision Restoration in Multiple Sclerosis
A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...
U.S. health regulator warns of serious allergic reactions with multiple sclerosis drugs
The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...
The Financial Express7d
USFDA issues warning of serious allergic reaction with multiple sclerosis drugs; Urges patients to be cautious
Patients should stop taking glatiramer acetate and seek immediate medical attention by going to an emergency room or calling ...
BioSpace7d
FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs
The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...